上海市浦东新区生物产业行业协会（SPBIA，以下简称“协会”）原名“上海市浦东新区生物医药协会”，成立于2002年9月12日，是由浦东新区民政局核准登记、生物医药企事业单位自愿参加、联合组织起来的社会团体。

       协会是浦东新区首批通过国家4A级认证的行业组织。国家“重大新药创制”科技重大专项技术副总师、中国科学院院士陈凯先担任会长。现有会员单位250多家，理事单位53家，现任理事有4位院士。会员单位涵盖浦东新区的生物、化学、中医药、医疗器械、服务外包等领域的企业，以及高等院校、科研院所、服务平台等单位。内设新药研发专委会、医疗器械专委会和科技评价委员会。

       协会适应产业创新发展和政府职能转移的需要，提升服务能级，年报编制、科技专项的组织实施，以及企业科技评价、技术对接、成果转化、国际合作、培训交流、会展论坛、信息资讯等领域开展了大量服务工作。

       协会的宗旨是遵守国家宪法、法律、法规；贯彻执行国家有关方针政策；履行行业服务、行业自律、行业统计、行业协调、行业培训、行业咨询、行业交流等职能，为浦东新区生物医药行业的企事业单位服务，在政府、科研机构、企业间发挥纽带和桥梁作用，推动生物医药产业的繁荣与发展。

About Chinese Biopharmaceutical Association (CBA), USA

The Chinese Biopharmaceutical Association-USA (CBA) (www.cba-usa.org) is one of the largest Chinese American professional associations in the US. Founded in 1995 by a group of Chinese-American biopharmaceutical professionals, CBA is an independent, non-political, and not-for-profit professional organization headquartered in the Washington DC area. The membership now comprises more than 3,000 biopharmaceutical related professionals from industry, academia, and government. Over 80 percent of the members hold Ph.D., M.D. and/or J.D. degrees. CBA also has over one hundred Institutional Members.

The mission of CBA is to promote communication and collaboration among biopharmaceutical professionals and to promote technology transfer and business collaborations among different countries and regions, especially between the United States, China, and other countries in the Pacific Rim.

Every year, CBA organizes and co-organizes a number of specially designed workshops, seminars, meetings, and networking gatherings to meet its members’ career advancement needs. As CBA’s most influential event, CBA’s annual conference attracts hundreds of attendees each year including many internationally renowned research scientists, business leaders, and high-ranking US and Chinese government officials. CBA has co-organized the annual Shanghai Bioforum with the Shanghai Municipal Government Commission of Science and Technology in 2008, the 1st Pearl River International Biopharmaceutical Forum held in Guangdong in 2009 and the 17th Annual CBA Conference in Qingdao in 2012.

CBA has undertaken many activities to strengthen relationships between China and the US and promote the Chinese biotechnology industry, holding seminars, conferences, and forums in major cities in China. CBA has an excellent reputation both in China and the U.S. for developing and enhancing friendship and cooperation within the biopharmaceutical and life sciences industries. Our efforts have been applauded by industry executives and prominent leaders from both US and China. The past Minister of Health of China, Dr. Chen Zhu, former US Deputy Secretary of Labor Sam Mok, former Chinese Ambassadors to US Wenzhong Zhou and Daoyu Li, and dozens of prominent leaders from academia, industry and government have attended and addressed CBA annual conferences.

Over the years, CBA has gained a great reputation in both China, US, as well as other parts of the world. As one of the most recognized Chinese American professional organizations in the US, CBA’s activities are popular among professionals with different cultural backgrounds. A number of prestigious scientific magazines, including Nature, Science, and Bioprocess International, have reported CBA, its event, as well as its members.

CBA just celebrated its 20th Anniversary in its New Year Gala in February 2015 and 20th annual conference in Chao Hu and Lian Yun Gang at the end of June 2015. The success of the organization can be attributed to the active involvement of members around the US who believe in its mission. Today, the global biopharmaceutical industry and healthcare continue to evolve and grow, particularly in China and the Asia Pacific area, and CBA members look up to participate in the challenges ahead.